Bridgefront Capital, LLC Ptc Therapeutics, Inc. Transaction History

Bridgefront Capital, LLC

  • $249 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$37.95 - $49.37 $251,760 - $327,520
-6,634 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$46.8 - $68.92 $32,151 - $47,348
687 Added 11.55%
6,634 $314,000
Q4 2020

Feb 12, 2021
BUY
$47.96 - $67.64 $285,218 - $402,255
5,947 New
5,947 $363,000

Others Institutions Holding PTCT

# of Institutions
222
Shares Held
78.1M
Call Options Held
144K
Put Options Held
58.7K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.29B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Bridgefront Capital, LLC Portfolio

Follow Bridgefront Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email